Founded:
2008
Headquarters:
Cambridge, MA
Description:
Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism.
Founders:
Lewis C. Cantley, Craig B. Thompson, Tak W. Mak
Categories:
Health Care, Biotechnology
Website:
http://www.agiospharmaceuticals.com

Detailed Description

Update

Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops therapeutics in the field of cancer metabolism.

It also develops drugs that focus on glycolysis, fatty acid metabolism, and autophagy. The company's therapeutics are used in the areas of autoimmune, inflammatory, and neurological diseases.

Agios Pharmaceuticals, Inc. was formerly known as CANCER METABOLISM THERAPEUTICS, INC. and changed its name to Agios Pharmaceuticals, Inc. in April 2008. The company is based in Cambridge, Massachusetts.

Current Team (12)

Update

Funding Rounds (3) - $86.8M

Update

Board Members and Advisors (17)

Update

Investors (4)

Update
  • 9f2b8ed799c4cab313f6ad0a4fb88958

    Third Rock Ventures

    Third Rock Ventures invests in transformational life science companies that show high growth...
  • 920ef1c9e2d2a1b871893ee51107f97c

    ARCH Venture Partners

    ARCH invests primarily in companies co-founded with leading scientists and entrepreneurs,...
  • 179e6f8b3e38a786db31104370625ec8

    Flagship Ventures

    Realizing entrepreneurial innovation is the mission of Flagship Ventures. The firm operates...
  • 1305f6cbf4005430f2e4db4c9e1d7cde

    Celgene

    Celgene discovers, develops and commercializes innovative therapies to treat cancer and...

Offices/Locations (1)

Update
  • Headquarters

    38 Sidney Street

    2nd Floor

    Cambridge, MA 02139

    USA

Images (1)

Update
  • 667d739f96ccad8df17521127ba8a51c